News

Throughout history and across cultures, monsters have helped communities teach lessons and affirm their values.

Suicide attempts among pregnant or postpartum mothers have nearly tripled over the past decade.

D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.

Drug use is not only a consequence of addiction. It can also be a response to a deeper, existential problem.

A mother begs the court to keep her son incarcerated for fear street gangs will eat him alive.

How has the COVID-19 pandemic affected the way young adults use substances like vaping, alcohol, and marijuana?

The COVID-19 pandemic has been a moment of truth for telehealth, and, by most accounts, the technology is rising to the challenge.

Key leaders experienced in real-world clinical practice share on a range of topics.

The high co-occurrence of chronic pain and PTSD and their possible entanglement underline the importance of conducting assessment for both conditions.

A prominent forensic psychiatrist and the grandson of founding father Alexander Hamilton, Allan McLane Hamilton, MD, was a proponent for the use of nitrous oxide for diagnostic and therapeutic use.

Pain may not often be considered within the realm of psychiatry; however, chronic pain's relationships with sleep disorders and PTSD make it an issue psychiatrists can—and should—address.

Sleep disturbance and chronic pain work together to cause misery for patients, with one exacerbating the other. Here: Tips to address both and bring peace to patients.

A well-meaning mental health initiative may be setting unrealistic expectations.

Telehealth poses challenges for patients, clinicians, families, and caregivers.

Physical activity and exercise are recognized as fundamental tools for reducing the impact of chronic diseases, including depression.

Recent research sheds light on the role of adjunctive long-acting injectable antipsychotics in treatment-resistant schizophrenia.

Fluvoxamine was not intended as a COVID-19 medication, but a recent study suggests it may help prevent serious complications for patients with COVID-19.

Potential relief for millions of Americans with pandemic-related sleep issues.

Facts and myths about depression during the holidays.

Manufacturing issues stall progress with ALKS 3831, Alkermes’s promising new drug for the treatment of schizophrenia and bipolar I disorder.

What is Zoom fatigue and is there a biopsychosocial explanation for this COVID-inspired phenomenon? The answer might surprise—and comfort—you.

First conceptualized over a century ago, conversion disorder continues to present a challenge to clinicians.

New research underlies the need for addressing identity in young patients during early stages of psychosis.

A new prescription smartwatch app may improve sleep quality for those with nightmare disorders.

Recently published data suggests a promising new treatment for patients with obsessive-compulsive disorder.

Good news in the fight against Alzheimer disease, with major progress in new, innovative treatments.

In this interview with Dr Aftab, Dr Dawson discusses how the rise of managed care industry and associated business forces have led to a profound deterioration of psychiatric practice environment in the United States.

An explanation for the clinical presentation of delusions and hallucinations may have just been found.

Learning from past disasters, psychiatrists are taking center staet in helping patients, family members, first responders, and other health care professionals affected by the COVID-19 pandemic.

A potential treatment for attention-deficit/hyperactivity disorder goes back to the drawing board.